IVIG for Hematologic Malignancy-Associated Secondary Immunosuppression: Key Insights, Based on the Latest Evidence
IVIG for hematologic malignancy-associated secondary immunosuppression may be an option when patients have severe or recurrent infections. Discover how IVIG is administered and find answers to the most common questions.
